Elixira has been fully designed as a technically feasible platform based on established scientific principles and proven technologies. A leading development partner has confirmed its buildability and expressed interest in supporting future implementation.
I am now seeking licensing partners specifically for human applications — organizations with the infrastructure, ethical standards, and global reach to bring Elixira into clinical development and scalable deployment.
Licensing terms are designed to support long-term growth, transparency, and aligned impact — with scalable benefits across both human and veterinary health markets.
If you represent a mission-aligned entity interested in advancing the future of preventive healthcare, I welcome the opportunity to begin that conversation.